Last updated on August 2019

Acute Treatment Trial in Adult Subjects With Migraines

Brief description of study

This study will evaluate the safety and efficacy of three different intranasal dose levels of BHV-3500, relative to placebo, in the acute treatment of moderate to severe migraine.

Clinical Study Identifier: NCT03872453

Find a site near you

Start Over

Wasatch Clinical Research, LLC

Salt Lake City, UT United States
  Connect »